Legal status · United States
Is Sermorelin with GHRP-2 and GHRP-6 legal in the United States?
Written by Aaron CuhaReviewed Sep 2026
Direct answer
No. Sermorelin with GHRP-2 and GHRP-6 is not an approved medicine in the United States; its classification is "Not approved; research use only". Nothing containing it is authorized for any use in people. Vials labeled "for research use only" are not exempt: that label does not make human use lawful. On the evidence, 4 human studies are cited on its profile.
Sermorelin with GHRP-2 and GHRP-6 in the United States at a glance
| Classification | Not approved; research use only |
|---|---|
| Note | Dispensed by compounding pharmacies on prescription. Compounded preparations are not FDA approved and are not reviewed for safety or efficacy. |
| FDA approval status | Not approved as a combination. Sermorelin held US approval and was withdrawn commercially; neither GHRP has ever been approved. |
| Human studies cited | 4 of 4 citations on the profile |
| Reviewed | Sep 2026 |
Classification and note come from the Sermorelin with GHRP-2 and GHRP-6 profile, checked against U.S. Food and Drug Administration (FDA) listings at the reviewed date.
What this means
- 01
No product containing Sermorelin with GHRP-2 and GHRP-6 is approved by FDA for any use in the United States, so nothing on the market is authorized for people.
- 02
"Research use only" is a vendor label, not a legal category that permits human use. It does not exempt a product from medicines law.
- 03
Importing, supplying or promoting it for human use can fall under medicines legislation in the United States. This page is general information, not legal advice.
What Sermorelin with GHRP-2 and GHRP-6 is
A long-standing compounded triple, commonly 3 mg of each in a 9 mg vial or 2 mg of each in a 6 mg vial. Two of the three components are agonists at the same ghrelin receptor, so this is two mechanisms with one delivered twice, and the second delivery is the component with the strongest appetite effect in the family.
This blend predates most of the market and it is still dispensed. The rationale offered is that GHRP-2 and GHRP-6 have slightly different profiles and that using both covers more ground.
Mechanism: Sermorelin is GHRH 1-29 and raises the amplitude of a growth hormone pulse at the GHRH receptor. GHRP-2 and GHRP-6 are both hexapeptide agonists at the growth hormone secretagogue receptor, triggering a pulse and opposing somatostatin tone, and both also drive appetite through the same receptor.
Regulatory history: Not approved as a combination. Sermorelin held US approval and was withdrawn commercially; neither GHRP has ever been approved.
How FDA treats this kind of product
Approves prescription drugs by indication and polices unapproved products, including peptides sold online. Compounding pharmacies may prepare some compounds under a prescription when the FDA places them on a permitted bulk-substances category.
The classification above is the The Longevity Archive reading of U.S. Food and Drug Administration listings for Sermorelin with GHRP-2 and GHRP-6 at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.
Sermorelin with GHRP-2 and GHRP-6 in other countries
Frequently asked questions
Is Sermorelin with GHRP-2 and GHRP-6 legal in the United States?
No. Sermorelin with GHRP-2 and GHRP-6 is not an approved medicine in the United States; its classification is "Not approved; research use only". Nothing containing it is authorized for any use in people. Vials labeled "for research use only" are not exempt: that label does not make human use lawful. On the evidence, 4 human studies are cited on its profile. Note: Dispensed by compounding pharmacies on prescription. Compounded preparations are not FDA approved and are not reviewed for safety or efficacy.
Can I buy Sermorelin with GHRP-2 and GHRP-6 in the United States?
No approved product exists to buy. In the United States Sermorelin with GHRP-2 and GHRP-6 is classified as "Not approved; research use only", so there is no licensed pharmacy product. Vendors selling it "for research use only" are not selling it for human use, and that label does not change its legal status. This site does not list or recommend vendors. Note: Dispensed by compounding pharmacies on prescription. Compounded preparations are not FDA approved and are not reviewed for safety or efficacy.
Is Sermorelin with GHRP-2 and GHRP-6 FDA approved?
No. FDA status: Not approved as a combination. Sermorelin held US approval and was withdrawn commercially; neither GHRP has ever been approved.. Current US classification: "Not approved; research use only". On the evidence, 4 human studies are cited on its profile.
Related compounds in the United States
Full research profile
Mechanism, cited studies, FDA status and the full legal summary for Sermorelin with GHRP-2 and GHRP-6 live on its compound profile.
Sermorelin with GHRP-2 and GHRP-6 profileThis page is general information about the regulatory status of Sermorelin with GHRP-2 and GHRP-6 in the United States, current as of Sep 2026. It is not legal advice, and classifications change; check U.S. Food and Drug Administration directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.